Literature DB >> 7852529

Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans.

E Oppenheimer1, B Linder, J DiMartino-Nardi.   

Abstract

Benign premature adrenarche (PA) is the term used to refer to girls with the early development of pubic hair before the age of 8 yr and is characterized by mild hyperandrogenism. Hyperandrogenism in adult women is often not as benign and has been associated with insulin resistance, acanthosis nigricans (AN), and the polycystic ovary syndrome. We have seen a group of young girls with PA who have also been found to have AN. The purpose of this study was to determine whether there are any clinical and biochemical differences in those girls with PA with and without AN. Twelve girls with PA were divided into two groups at the time of evaluation: group I, those without AN (n = 5); and group II, those with AN (n = 7). Adrenal androgen levels were determined in all subjects by a 60-min ACTH stimulation test. Insulin sensitivity was measured by the frequently sampled iv glucose tolerance test with tolbutamide and was assessed using the modified minimal model. Mean chronological age, bone age, and weight for length index were similar in the two groups. The baseline and stimulated levels of adrenal androgens were also not significantly different between the two groups. The group I girls (without AN) had an insulin sensitivity index of 6.75 +/- 1.31, which was in the normal prepubertal range. This was significantly different from that in group II (with AN), who had an insulin sensitivity index of 3.69 +/- 1.29. Therefore, many girls with premature adrenarche can have AN and decreased insulin sensitivity. Whether these girls have a truly benign course or are at risk of ovarian dysfunction or carbohydrate intolerance needs to be assessed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852529     DOI: 10.1210/jcem.80.2.7852529

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  [Childhood acne. Clinical expression, etiology, and relationship to juvenile acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

Review 2.  Defects of steroidogenesis.

Authors:  A Biason-Lauber; M Boscaro; F Mantero; G Balercia
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

3.  The Relationship of Metabolic Syndrome and Body Composition in Children with Premature Adrenarche: Is It Age Related?

Authors:  Kristen M Williams; Sharon E Oberfield; Chengchen Zhang; Donald J McMahon; Aviva B Sopher
Journal:  Horm Res Paediatr       Date:  2015-10-30       Impact factor: 2.852

Review 4.  Premature adrenarche.

Authors:  P Saenger; J Dimartino-Nardi
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

Review 5.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

6.  Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis.

Authors:  Meng Kian Tee; Walter L Miller
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

7.  Approach to the girl with early onset of pubic hair.

Authors:  Sharon E Oberfield; Aviva B Sopher; Adrienne T Gerken
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

Review 8.  Androgen synthesis in adrenarche.

Authors:  Walter L Miller
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

Review 9.  The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.

Authors:  R B Barnes
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

10.  Utility of early insulin response and proinsulin to assess insulin resistance.

Authors:  Amy M Jean; Abeer Hassoun; Jennifer Hughes; Christy Pomeranz; Ilene Fennoy; Donald J McMahon; Sharon E Oberfield
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.